Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Invested Capital (2018 - 2021)

Historic Invested Capital for Black Diamond Therapeutics (BDTX) over the last 4 years, with Q3 2021 value amounting to $218.9 million.

  • Black Diamond Therapeutics' Invested Capital fell 3315.28% to $218.9 million in Q3 2021 from the same period last year, while for Sep 2021 it was $218.9 million, marking a year-over-year decrease of 3315.28%. This contributed to the annual value of $307.8 million for FY2020, which is 75262.42% up from last year.
  • Black Diamond Therapeutics' Invested Capital amounted to $218.9 million in Q3 2021, which was down 3315.28% from $251.0 million recorded in Q2 2021.
  • Black Diamond Therapeutics' Invested Capital's 5-year high stood at $356.2 million during Q1 2020, with a 5-year trough of -$47.2 million in Q4 2019.
  • Its 4-year average for Invested Capital is $161.2 million, with a median of $235.0 million in 2021.
  • Per our database at Business Quant, Black Diamond Therapeutics' Invested Capital tumbled by 24085.29% in 2019 and then soared by 194775.66% in 2020.
  • Over the past 4 years, Black Diamond Therapeutics' Invested Capital (Quarter) stood at -$13.8 million in 2018, then crashed by 240.85% to -$47.2 million in 2019, then skyrocketed by 752.62% to $307.8 million in 2020, then decreased by 28.86% to $218.9 million in 2021.
  • Its Invested Capital stands at $218.9 million for Q3 2021, versus $251.0 million for Q2 2021 and $280.8 million for Q1 2021.